Prostate Cancer - Results from #40

Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? March 23, 2023

Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs. March 23, 2023

Palette Life Sciences Announces Transaction with Global Healthcare Investor OrbiMed March 22, 2023

Understanding the sexual health perceptions, concerns, and needs of female partners of prostate cancer survivors. March 22, 2023

Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study). March 22, 2023

Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer. March 22, 2023

First-line pembrolizumab plus androgen deprivation therapy for locally advanced microsatellite instability-high prostate cancer in a patient with Muir-Torre syndrome: A case report. March 22, 2023

Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study. March 22, 2023

Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT. March 22, 2023

Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. March 22, 2023

RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis. March 22, 2023

Value Based Payment Shift for Independent Urology Practices: Roadmap and Barriers March 21, 2023

Artera Launches with $90 Million in Funding to Personalize Cancer Therapy with Multimodal AI March 21, 2023

Disparities in Genitourinary Cancers Incidence and Mortality in the United States - Expert Commentary March 21, 2023

Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy. March 21, 2023

Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy. March 21, 2023

Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations of an International Panel. March 21, 2023

Nutrition Guidance for Patients on Androgen Deprivation Therapy. March 21, 2023

Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2). March 21, 2023

Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry. March 21, 2023

Page 3 of 1290